Holen Sie sich die Stockscreener-App
0.645
0.76%
-0.00495
Schlusskurs vom Vortag:
$0.6499
Offen:
$0.65
24-Stunden-Volumen:
36,678
Relative Volume:
0.60
Marktkapitalisierung:
$1.67M
Einnahmen:
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-0.1245
EPS:
-5.1824
Netto-Cashflow:
$-18.40M
1W Leistung:
-22.95%
1M Leistung:
-40.83%
6M Leistung:
-81.68%
1J Leistung:
-97.35%
1-Tages-Spanne:
$0.6293
$0.66
1-Wochen-Bereich:
$0.62
$0.8311
52-Wochen-Spanne:
$0.62
$27.04
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Firmenname
Calidi Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 794-9600
Adresse
4475 Executive Drive, Suite 200, San Diego
Compare CLDI vs VRTX, REGN, MRNA, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
0.645 | 1.67M | 0 | -25.09M | -18.40M | -5.1824 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-10-09 | Eingeleitet | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
Tangible book value per share of Calidi Biotherapeutics, Inc. – AMEX:CLDI - TradingView
Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026 - GlobeNewswire
Mouse data will show high rates of complete tumor elimination with Calidi's tumor-targeting virus. - Stock Titan
Enterprise value to EBITDA forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Calidi Biotherapeutics (NYSEAMERICAN:CLDI) Races to Fix an Equity Shortfall Before Delisting - kalkine.ca
Calidi Biotherapeutics Addresses NYSE American Compliance Notice - The Globe and Mail
Calidi Biotherapeutics Received Notice of Noncompliance - TradingView
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency - GlobeNewswire Inc.
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency - GlobeNewswire
Calidi Biotherapeutics Announces Registered Direct Stock Offering - The Globe and Mail
Calidi Biotherapeutics Finalizes $1.2M Registered Direct Stock Offering - Kalkine Media
Calidi Biotherapeutics Raises $1.2 Million in Registered Direct Offering at $1.17 Per Share - tradingview.com
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - Quiver Quantitative
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - GlobeNewswire
A biotech plans to raise about $1.2 million by selling shares at $1.17 each. - Stock Titan
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering - Yahoo Finance
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
CLDI Q4 2025 Earnings: Loss Narrows Sharply, Beating Estimates by 73.59%; Shares Rise 3.41%Dividend Earnings Report - vinanet.vn
ARMISTICE CAPITAL, LLC Slashes Calidi Biotherapeutics (CLDI) Sta - GuruFocus
Calidi (CLDI) Quarterly Scorecard: EPS Exceeds Its Estimate in Latest Trading; Market Response: Shares Move Lower 2.90%Dividend Cut Risk - vinanet.vn
Calidi Biotherapeutics (CLDI) grants director 5,000 options - Stock Titan
Calidi director granted 4,000 options at $1.36 | CLDI Insider Trading - Stock Titan
Calidi Biotherapeutics (CLDI) gives CFO 14,000 options with 10-year term - Stock Titan
Calidi Biotherapeutics (CLDI) awards director 4,000 options vesting in 1 year - Stock Titan
Calidi Biotherapeutics (CLDI) CEO awarded 32K options vesting over 4 years - Stock Titan
Calidi Biotherapeutics (CLDI) awards 16,000 options to CSO - Stock Titan
Calidi (CLDI) Report Card: The EPS Result Is Above Expectation in the Current Update; Reaction Snapshot: Shares Close 6.62% Lower in the Latest SessionTrough Earnings Signal - vinanet.vn
Calidi (CLDI) Closing Snapshot: Retreats 5.59% to $1.28 in the Current Update; Technical Position: the Near-Term Reference Band Stretches From $1.22 to $1.34 on the DayCalendar Spread Trade - vinanet.vn
Calidi Biotherapeutics Granted Patent for Cell-Based Oncolytic Virus Immunotherapy for Cancer Treatment - ACCESS Newswire
Armistice Capital reports 4.99% Calidi Biotherapeutics (CLDI) stake in Schedule 13G/A - Stock Titan
Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com Nigeria
Calidi Biotherapeutics Reports Quarterly Results and Pipeline Progress - TipRanks
Calidi Biotherapeutics Q2 net loss narrows to $4.2M; G&A cuts 48% - scanx.trade
Calidi Biotherapeutics 2Q 2026: Net loss $4.16M, EPS $(2.94) — 10-Q Summary - TradingView
Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com Canada
Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com India
Calidi Biotherapeutics Reports Positive FDA Pre-IND Feedback for CLD-401, Showcases RedTail Platform Data and Cuts G&A Expenses - Quiver Quantitative
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Yahoo Finance
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswire
Price to book forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Price to sales forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView
Calidi Biotherapeutics (CLDI) Holds Steady at $1.63 as Stock Sits Between Support and ResistanceEntry Point Alerts - dars.gov.et
CLDI Q4 2025 Earnings: Narrower Loss of -$0.43 Per Share Beats Estimates, Stock Falls 9.5%High Estimate Range - vinanet.vn
Calidi Biotherapeutics (CLDI) Insider Trading Activity 2026 $CLDI - MarketBeat
Calidi Biotherapeutics Inc (CLDI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Calidi Biotherapeutics (CLDI) Falls 6.88% to $1.76, Pressing Key Support at $1.67Straddle Setup - vinanet.vn
Calidi Biotherapeutics (CLDI) Jumps 12.5% to $1.89 as Bullish Momentum Builds Toward $1.98 ResistanceSector Neutral Pair - vinanet.vn
Price to sales forward of Calidi Biotherapeutics, Inc. – BOATS:CLDI - TradingView
Calidi Biotherapeutics Inc. (NYSE: CLDI) Share Price, CLDI Stock News, CLDI Share Price & Updates - Kalkine
Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):